Maximize Benefits of SGLT2 Inhibitors in People with Advanced CKD Stages with Type 2 Diabetes

被引：0
|
作者：
Kashima, Koji
Shimizu, Hiroyuki
Yamada, Masanobu
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-878-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
878-P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    [J]. CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [2] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Rohit Singhal
    Lisa Aimee Hechanova
    [J]. Current Cardiology Reports, 2022, 24 : 183 - 189
  • [3] SGLT2 inhibitors in diabetes with CKD
    Malik, A. H.
    Yandrapalli, S.
    Goldberg, M.
    Jain, D.
    Frishman, W. H.
    Aronow, W. S.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
  • [4] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    [J]. ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [5] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Evans, Marc
    Hicks, Debbie
    Patel, Dipesh
    Patel, Vinod
    McEwan, Phil
    Dashora, Umesh
    [J]. DIABETES THERAPY, 2020, 11 (01) : 37 - 52
  • [6] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Marc Evans
    Debbie Hicks
    Dipesh Patel
    Vinod Patel
    Phil McEwan
    Umesh Dashora
    [J]. Diabetes Therapy, 2020, 11 : 37 - 52
  • [7] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [8] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Beatrice C. Lupsa
    Silvio E. Inzucchi
    [J]. Diabetologia, 2018, 61 : 2118 - 2125
  • [9] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Lupsa, Beatrice C.
    Inzucchi, Silvio E.
    [J]. DIABETOLOGIA, 2018, 61 (10) : 2118 - 2125
  • [10] Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Marc Evans
    Debbie Hicks
    Dipesh Patel
    Vinod Patel
    Phil McEwan
    Umesh Dashora
    [J]. Diabetes Therapy, 2020, 11 : 571 - 571
12345